CD274 and cancer: Especially, antibodies against PD-1 and PD-L1 have prominent effects in various malignant tumors (Brahmer et al., 2010[4]; Garon et al., 2015[6]; Herbst et al., 2014[11]; Topalian et al., 2012[30]).